Palisade Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-7,592
Closed -$1.34M 426
2020
Q1
$1.34M Buy
7,592
+1,600
+27% +$301K 0.05% 302
2019
Q4
$1.15M Sell
5,992
-800
-12% -$144K 0.03% 326
2019
Q3
$1.14M Sell
6,792
-500
-7% -$81.5K 0.03% 323
2019
Q2
$1.22M Sell
7,292
-700
-9% -$96.9K 0.04% 324
2019
Q1
$1.17M Buy
7,992
+100
+1% +$14.5K 0.04% 322
2018
Q4
$1.05M Sell
7,892
-1,000
-11% -$164K 0.04% 322
2018
Q3
$1.69M Sell
8,892
-4,000
-31% -$735K 0.05% 317
2018
Q2
$2.15M Sell
12,892
-3,729
-22% -$599K 0.06% 287
2018
Q1
$2.8M Buy
16,621
+11,000
+196% +$1.85M 0.09% 260
2017
Q4
$919K Buy
+5,621
New +$1.01M 0.03% 338
2015
Q1
Sell
-5,850
Closed -$1.51M 516
2014
Q4
$1.51M Buy
+5,850
New +$1.46M 0.04% 348
2014
Q3
Sell
-2,767
Closed -$617K 507
2014
Q2
$617K Buy
+2,767
New +$573K 0.01% 409

Other funds holding AGN

Palisade Capital Management's AGN Position: Q2 2020 in Review

Palisade Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,592 shares — an estimated $1.34M sold.

Palisade Capital Management first reported a position in AGN in Q2 2014 and held it in 12 quarters. The position peaked at $2.8M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Palisade Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Palisade Capital Management sold 7,592 Allergan plc shares in Q2 2020, an estimated $1.34M.
  • Palisade Capital Management first reported a position in Allergan plc in Q2 2014 and held it in 12 quarters.
  • Palisade Capital Management's Allergan plc position peaked at $2.8M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Palisade Capital Management's 13F filing for Q2 2020, filed 6 Aug 2020.